Leads Translational Research VP area covering biomarker discovery, qualification & and assay development in Research & Early Development. Team consists
of biomarker strategists, wet-lab scientists and technicians. Applied methods & technologies include transcriptomics, proteomics, peptidomics, lipidomics & metabolomics, flow
cytometry, imaging, ligand binding assays as well as acquiring and analyzing samples from cohorts and clinical trials.
Represents Global Translation CVP area in pre-project approval board and biology design review meeting in early stages of drug discovery & development and
is member of Translation Forum and Global Translation Leadership team.